4 hours SOLV Stock Gains as Q3 Earnings & Sales Beat Estimates, ’24 View UpZacks
Solventum’s top line reflects the favorable impact of pricing normalization. Organic growth is primarily driven by rising demand for MedSurg products. The higher EPS outlook looks promising.
X